Latest filing published 07 Oct 2026 for TriSalus Life Sciences, Inc., €1,270. Read the official filing
Richard Marshak appears in our data through filings on TriSalus Life Sciences, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 12 February 2024 to 5 October 2026, the count stands at 8 filings.
No open-market purchase appears, only 2 sales worth €6,424. Besides market trades, the filings include 6 share grants. So far in 2026, the count stands at no purchases and 2 sales.
On 7 October 2026 came the latest disclosure, an open-market sale for €1,270 in TriSalus Life Sciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations